📋 BASDAI Calculator

The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is the standard patient-reported measure of how active ankylosing spondylitis is. Six questions cover fatigue, spinal pain, other joint pain, tender areas, and morning stiffness, each scored 0 to 10 for the past week.

The total runs 0 to 10, and 4.0 is the line that matters: scores at or above 4 indicate active disease and are widely used as the threshold for starting or switching biologic therapy. This calculator scores the six questions and applies the cutoff.

How to use this calculator

Think about the past week and rate each symptom honestly from 0 (none) to 10 (very severe).

The formula

The two morning-stiffness questions are averaged first (they measure one symptom), then all five components are averaged.

The 4.0 cutoff is not arbitrary: it anchors treatment guidelines in many countries for biologic eligibility, and trials use BASDAI improvement (often 50% or 2 points) as the response measure.

Worked example

Fatigue 6, spinal pain 5, other joints 7, tender areas 4, stiffness severity 8, stiffness duration 6. BASDAI = (6 + 5 + 7 + 4 + (8+6)/2) / 5 = (22 + 7) / 5 = 5.8. Active disease, above the 4.0 threshold: this is the conversation about treatment escalation with the rheumatologist.

Contrast scores of 2, 3, 2, 1, 3, 2: (2+3+2+1+2.5)/5 = 2.1. Low disease activity: current management is working.

What the score means for treatment

Below 4.0: low activity. Continue current therapy, keep monitoring, and maintain exercise, which is the one intervention that helps at every level. At or above 4.0: active disease. Guidelines in many health systems use this cutoff for biologic therapy (TNF or IL-17 inhibitors), alongside objective inflammation markers like CRP and MRI findings.

The score is also the yardstick for response: a drop of 2 points or 50 percent typically defines a meaningful improvement. For related musculoskeletal screening, see our Beighton hypermobility score and Berg balance scale.

Morning stiffness: the signature symptom

Inflammatory back pain behaves opposite to mechanical back pain: it worsens with rest, improves with movement, and comes with morning stiffness lasting 30+ minutes. That pattern is why two of the six BASDAI questions target morning stiffness, and why rheumatologists ask about it first.

Tracking stiffness duration separately from severity is useful because they diverge: treatment may cut duration from 2 hours to 20 minutes while severity lingers, and that improvement still counts as a win worth reporting.

Limits of a symptom score

BASDAI measures symptoms, not damage. Someone with burned-out, fused disease can score low while carrying major structural change, and someone with fibromyalgia overlap can score high without active spinal inflammation. Rheumatologists pair it with CRP, ESR, and MRI to separate symptom burden from inflammatory activity.

Score consistently for tracking: same day of the week, same time of day, thinking about the same "past week." BASDAI's value multiplies when trended across visits, turning vague "about the same" into a number.

BASDAI vs ASDAS: the newer activity score

BASDAI has a younger rival. The Ankylosing Spondylitis Disease Activity Score (ASDAS) mixes four patient questions with a blood marker, CRP or ESR, into a formula that grades activity in four states: under 1.3 is inactive, 1.3 to 2.1 moderate, 2.1 to 3.5 high, and over 3.5 very high disease. Trials have largely moved to ASDAS because the lab value anchors the subjectivity.

BASDAI still wins at the bedside. It needs no blood draw, no calculator beyond averaging, and patients can complete it in the waiting room. Many rheumatologists track both: BASDAI for the quick read at every visit, ASDAS when deciding about biologics or judging trial-level response. A BASDAI of 5 with a normal CRP tells a different story than a BASDAI of 5 with a CRP of 40, and having both numbers keeps that distinction visible.

For self-tracking, BASDAI's simplicity is the point. Score it the same way each time and the trend line is honest. If your clinic uses ASDAS, ask for the CRP alongside your BASDAI so you can see how the two move together.

Tracking BASDAI between visits

A single BASDAI is a snapshot; a year of them is a story. Score yourself monthly, or weekly during flares, and bring the trend to appointments. Rheumatologists make better decisions from a falling 6-4-3 than from a one-time 4 described as "about the same as usual."

Define your flare threshold in advance. A rise of 2 or more points that lasts over a week is the commonly used definition, and having it written down stops the "should I call?" dithering. Note what was happening alongside: infections, stress, missed doses, weather changes people swear by. Patterns emerge that memory alone misses.

Keep the method boring and consistent: same day, same time, same honest 0-to-10 scale. Phone notes apps work fine; dedicated symptom trackers add graphs. The discipline matters more than the tool, because the value is all in the comparability.

For informational purposes only, not medical advice. Consult a healthcare professional.